Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a complex multifactorial brain disorder with a genetic component. Convergent evidence has implicated oxidative stress and glutathione (GSH) deficits in the pathogenesis of this disease. The aim of the present study was to test whether schizophrenia is associated with a deficit of GSH synthesis. Cultured skin fibroblasts from schizophrenia patients and control subjects were challenged with oxidative stress, and parameters of the rate-limiting enzyme for the GSH synthesis, the glutamate cysteine ligase (GCL), were measured. Stressed cells of patients had a 26% ( P = 0.002) decreased GCL activity as compared with controls. This reduction correlated with a 29% ( P < 0.001) decreased protein expression of the catalytic GCL subunit (GCLC). Genetic analysis of a trinucleotide repeat (TNR) polymorphism in the GCLC gene showed a significant association with schizophrenia in two independent case-control studies. The most common TNR genotype 7/7 was more frequent in controls [odds ratio (OR) = 0.6, P = 0.003], whereas the rarest TNR genotype 8/8 was three times more frequent in patients (OR = 3.0, P = 0.007). Moreover, subjects with disease-associated genotypes had lower GCLC protein expression ( P = 0.017), GCL activity ( P = 0.037), and GSH contents ( P = 0.004) than subjects with genotypes that were more frequent in controls. Taken together, the study provides genetic and functional evidence that an impaired capacity to synthesize GSH under conditions of oxidative stress is a vulnerability factor for schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several divergent genetic (e.g. Gclc, Gclm, Disc1, PRODH, G72, NRG1) (9–17) or external factors (e.g. stress, social isolation, ketamine, neonatal ventral hippocampal lesion) (18–24) collectively lead to redox dysregulation.”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [9]
In the citing paper
“PVIs are highly sensitive to redox status and ROS signalling.”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [46]
In the citing paper
“Mice deficient in the GCL regulatory subunit Gclm have reduced brain GSH levels and exhibit schizophrenia-relevant behavioural and cognitive deficits, including altered stress responses, amphetamine responses, social behaviour, prepulse inhibition (PPI) and learning 46,47 ,.”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [46]
In the citing paper
“For example, neuron-specific reduction of the levels of selenoproteins (a group of proteins that include several antioxidants) selectively impaired PVI development 58 , which was also observed in the prefrontal and ventral hippocampal regions in Gclm-deficient mice 46,59,60 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [46]
Citations
Cites
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Diagnostic Interview for Genetic Studies: Rationale, Unique Features, and Training
Nurnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,053
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Glutathione, oxidative stress and neurodegeneration
Schulz, J. B., Lindenau, J., Seyfried, J., & Dichgans, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01595.x · Cited by 1,213
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Dringen, R., Gutterer, J. M., & Hirrlinger, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01597.x · Cited by 760
Piazza, P. V., & Le Moal, M. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002043 · Cited by 690
Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 686
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Self-citationChemical and molecular regulation of enzymes that detoxify carcinogens.
Prestera, T., Holtzclaw, W. D., Zhang, Y., & Talalay, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2965 · Cited by 421
Energetics of Functional Activation in Neural Tissues
Sokoloff, L. (1999) · Neurochemical Research · doi:10.1023/a:1022534709672 · Cited by 373
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phase II inducers
Satoh, T., Okamoto, S.-I., Cui, J., Watanabe, Y., Furuta, K., Suzuki, M., Tohyama, K., & Lipton, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505723102 · Cited by 341
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321
Preisig, M., Fenton, B. T., Matthey, M.-L., Berney, A., & Ferrero, F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050084 · Cited by 307
Self-citationOwen, M. J., Craddock, N., & O'Donovan, M. C. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.06.011 · Cited by 307
Role of HER2 gene overexpression in breast carcinoma
M�nard, S., Tagliabue, E., Campiglio, M., & Pupa, S. M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2<150::aid-jcp3>3.0.co;2-e · Cited by 303
Fluorescence-based microtiter plate assay for glutamate–cysteine ligase activity
White, C. C., Viernes, H., Krejsa, C. M., Botta, D., & Kavanagh, T. J. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00143-x · Cited by 293
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse
Yang, Y., Dieter, M. Z., Chen, Y., Shertzer, H. G., Nebert, D. W., & Dalton, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209372200 · Cited by 269
Kolluri, N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1200 · Cited by 241
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234
Self-citationSerious Cardiovascular Events and Mortality Among Patients with Schizophrenia
Enger, C., Weatherby, L., Reynolds, R. F., Glasser, D. B., & Walker, A. M. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000105996.62105.07 · Cited by 215
Cardiovascular Disease in Patients With Schizophrenia in Saskatchewan, Canada
Curkendall, S. M., Mo, J., Glasser, D. B., Stang, M. R., & Jones, J. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0519 · Cited by 200
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173
Self-citation[3] Glutathione biosynthesis and its inhibition
Meister, A. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)52005-8 · Cited by 171
Schwab, S. G., Hallmayer, J., Albus, M., Lerer, B., Eckstein, G. N., Borrmann, M., Segman, R. H., Hanses, C., Freymann, J., Yakir, A., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000791 · Cited by 167
Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia
Grima, G., Benz, B., Parpura, V., Cuénod, M., & Do, K. Q. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00405-x · Cited by 156
Self-citationKoide, S., Kugiyama, K., Sugiyama, S., Nakamura, S., Fukushima, H., Honda, O., Yoshimura, M., & Ogawa, H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02866-8 · Cited by 131
Multi-faceted regulation of ?-glutamylcysteine synthetase
Soltaninassab, S. R., Sekhar, K. R., Meredith, M. J., & Freeman, M. L. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2<163::aid-jcp4>3.0.co;2-1 · Cited by 123
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96
Self-citationCabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 94
Self-citationChakraborti, A., Gulati, K., Banerjee, B. D., & Ray, A. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.018 · Cited by 80
Do, K. Q., Lauer, C. J., Schreiber, W., Zollinger, M., Gutteck‐Amsler, U., Cuénod, M., & Holsboer, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062652.x · Cited by 79
Self-citationDahl, N. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1147 · Cited by 72
Castagné, V., Rougemont, M., Cuénod, M., & Kim, Q. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.005 · Cited by 71
Self-citationThe Molecular Basis of a Case of γ-Glutamylcysteine Synthetase Deficiency
Beutler, E., Gelbart, T., Kondo, T., & Matsunaga, A. T. (1999) · Blood · doi:10.1182/blood.v94.8.2890.420k16_2890_2894 · Cited by 63
Walsh, A. C. (2001) · Toxicological Sciences · doi:10.1093/toxsci/61.2.218 · Cited by 60
Castagné, V., Cuénod, M., & Do, K. Q. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.012 · Cited by 53
Self-citationSchizophrenia: an integrative approach to modelling a complex disorder
Robertson, G. S., Hori, S. E., & Powell, K. J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0619 · Cited by 41
Research works printed but not linked: 2
- KQ Do, P Bovet, JH Cabungcal, P Conus, R Gysin, S Lavoie, P Steullet, M Cuenod Schizophrenia, Handbook of Neurochemistry and Molecular Neurobiology, ed A Lajtha (Springer, 3rd Ed, New York, in press. (2007).
- GS Robertson, SE Hori, KJ Powell J Psychiatry Neurosci 31, 157–167 (2006).
Cited by
Regulation of glutathione synthesis
Lu, S. C. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,116
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
Self-citationOxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
“, 2006) Glutamate cysteine ligase catalytic (GCLC) subunit 388 (Gysin et al., 2007) Manganese-SOD (-9Ala allele) 153 (Akyol et al.”
BackgroundMoghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Metadata
- Authors
- Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., Tosic, M., Werge, T., Cuénod, M., & Do, K. Q.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Lausanne (CH)
- *Center for Psychiatric Neuroscience and
- Sankt Hans Hospital (DK)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-10-16
- Volume
- 104
- Issue
- 42
- Pages
- 16621-16626
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2034265
- OpenAlex
- W2043523067
- Cited by
- 309
- References
- 38
- Citations by year
- 2026: 10 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 16 · 2021: 15 · 2020: 9 · 2019: 8 · 2018: 16 · 2017: 22 · 2016: 15 · 2015: 16 · 2014: 27 · 2013: 21 · 2012: 18
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Keywords
- schizophrenia, glutathione synthesis, gamma-glutamylcysteine synthetase, GCLC, oxidative stress, trinucleotide repeat polymorphism, genetic susceptibility, dermal fibroblasts, glutathione deficiency, vulnerability factors
- MeSH terms
- Cells, Cultured, Female, Fibroblasts, Glutamate-Cysteine Ligase, Glutathione, Humans, Male, Polymorphism, Genetic, Schizophrenia, Skin, Case-Control Studies, Oxidative Stress, Trinucleotide Repeats, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.